Source comparison
CJC-1295 No DAC & Ipamorelin: Research Peptide Comparison
| Peptide | Mechanism | Half-Life | GH Peak (ng/mL) | Cortisol/Prolactin Effect | Typical Research Dose | Professional Assessment ||—|—|—|—|—|—|| CJC-1295 no DAC | GHRH analog. Extends GHRH signaling without receptor downregulation | ~30 minutes | 8–12 (solo)
This comparison does not assign a generated winner or score.
- | Peptide | Mechanism | Half-Life | GH Peak (ng/mL) | Cortisol/Prolactin Effect | Typical Research Dose | Professional Assessment ||—|—|—|—|—|—|| CJC-1295 no DAC | GHRH analog. Extends GHRH signaling without receptor downregulation | ~30 minutes | 8–12 (solo) | None | 100–200 mcg, 1–2× daily | Gold standard for pulsatile GHRH stimulation; preserves natural GH rhythm || Ipamorelin | Selective ghrelin receptor agonist. Stimulates GH without ACTH/cortisol activation | ~2 hours | 10–15 (solo) | None | 200–300 mcg, 1–2× daily | Most selective ghrelin mimetic; ideal for recovery without metabolic disruption || CJC-1295 + Ipamorelin (combined) | Dual-pathway synergistic GH secretion | N/A (stacked dosing) | 25–40 (combined) | None | 100 mcg CJC + 200 mcg Ipa | Synergistic amplification produces sustained GH elevation 2.5–4× higher than solo peptides || GHRP-2 | Non-selective ghrelin agonist | ~30 minutes | 12–18 (solo) | Moderate cortisol elevation | 100–300 mcg | Effective but less selective
- The comparison underscores why does CJC-1295 no DAC & Ipamorelin help recovery research protocols favor this stack: you get the highest GH secretion without cortisol interference, preserved pulsatility without receptor desensitization, and dosing flexibility that aligns with circadian recovery windows.